Autoimmune & Inflammatory
Also called Takayasu Disease, Aortoarteritis, Pulseless Disease
Takayasu Arteritis is a chronic, granulomatous inflammatory disease of large elastic arteries, particularly the aorta and its proximal branches. The pathophysiology involves T cell-mediated inflammatory infiltration of the vessel wall, leading to intimal thickening, medial hypertrophy, fibrosis, and vascular remodeling.
Takayasu Arteritis predominantly affects young women aged 10-40 years, with 80% of cases occurring in females. The disease most commonly affects populations from Asia (particularly East and Southeast Asia), Africa, India, and the Middle East. It is much less common in Caucasian populations and North America. Disease can manifest in childhood or adolescence. Pregnancy-related disease activity occurs in some women.
Clinical trials for Takayasu Arteritis focus on immunosuppressive and biologic therapies, particularly TNF inhibitors and newer targeted therapies. Trials investigate optimal induction and maintenance therapy, combination approaches, and strategies to prevent relapses and organ complications. Trials examining mycophenolate mofetil, tocilizumab, and other biologics are ongoing. Management involves controlling inflammation, monitoring vascular complications, and managing hemodynamic sequelae. Patients should consult with a rheumatologist experienced in vasculitis.
Giant Cell Arteritis is a rare inflammatory disease of large and medium-sized arteries, primarily affecting people over ...
Granulomatosis with Polyangiitis is a rare autoimmune disease causing inflammation of small and medium blood vessels in ...
Behçet Disease is a rare, chronic, recurrent vasculitis causing painful oral and genital ulcers, eye inflammation, and s...